ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.75
0.00 (0.00%)
05 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.75 1.70 1.80 1.75 1.75 1.75 250,114 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.34 13.57M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.75p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £13.57 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.34.

Shield Therapeutics Share Discussion Threads

Showing 3251 to 3273 of 23475 messages
Chat Pages: Latest  135  134  133  132  131  130  129  128  127  126  125  124  Older
DateSubjectAuthorDiscuss
22/5/2019
15:28
Yes, only 117m shares market cap really is peanuts if they get approval, ok I'm bias but 90% confident, simply because excellent product and its not life threatening, I think but I'm not as doctor. But the benefits are massive to a patient. Surely FDA will say YES.
montyhedge
22/5/2019
15:07
Hey Monty, presumably you have been in for a while?

Onwards & upwards

ny boy
22/5/2019
14:47
I'm 90% confident of approval its not a life threatening drug has I understand, so FDA giving it the nod seems nailed on to me, for the benefit its gives patients. I see the share price doubling coming months after 27th if given the ok, as deals get signed.
Lets hopefully enjoy the ride.

montyhedge
22/5/2019
14:43
More buying, gobbling up a few sellers
ny boy
22/5/2019
12:52
Listening to that podcast with the CEO, the only risk, which seems reduced, is we don’t want a CRL from the FDA, it’s not as bad as rejection but it would cause the share price to obviously drop, which if it happened, might be viewed as a buying opportunity but depends on what the CRL contents are.

Still I am 75% confident of approval but everyone has to dyor

The U.S. Food and Drug Administration (FDA) sends a complete response letter (CRL) to communicate it has completed its review of a new or generic drug application, and it decided that it will not approve it for marketing in its present form. Receiving one of these letters from the FDA is never good news, but their long-term impact varies.


I reckon around 150p up to 27 July but with heightened volatility the week before, certainly exciting few months!

So far, there seems very little reason to sell, as there is still lots of buying interest, every mini pull back, has been bought!

ny boy
22/5/2019
12:47
Does anyone know of an example of a drug where FDA has been rejected following EU approval?
78steve
22/5/2019
12:39
No ......77.5% ...now that's fair
kop202
22/5/2019
11:16
I think 80% is fair. But unlike my last bet on immu this has still has value if fda say no. I would see the negative outcome as being a request for more date + fast track approval. But not too sure what the share price would do in that case. I see significant gains before July here anyway IMO.
jimbob49
22/5/2019
11:07
Let’s say 75%! Looking good though! 👌🤞
ny boy
22/5/2019
10:53
I dont want to be too optimistic however with the director buys and the way this is moving i feel it is almost 100% certain that we will get approval on the 27th of July
sharestobuy
22/5/2019
10:46
Thank you - a good listen.
2theduke
22/5/2019
09:43
Podcast interview with CEO, discusses FDA from ~9 mins
paleje
22/5/2019
09:36
I loaded up at 100p area.

Lets see if we can close above 115p, if there is a pull back I will add more but I don’t need anymore at this juncture. I suspect there will be plenty of buying interest if there is a pull back, as many missed earlier pull backs! GLA

ny boy
22/5/2019
08:39
Ok so I bought a few more this morning. I thought 115p was going to be a barrier but certainly no sign of any selling at this level. Onwards and upwards...
nobbygnome
22/5/2019
08:22
Morning STX’ers,

Trying to break 115p, buying resumes

ny boy
21/5/2019
18:40
Topped up at £1.15. Hoping for £3 or more by end of July
sharestobuy
21/5/2019
16:32
Onwards and upwards, not sure if we can break 115p today but it’s coming, no reason to sell imo

Market closed but note a big volume day!

ny boy
21/5/2019
15:12
Widening the spread to try and flush out a few weak holders at 115 resistance, buyers to counter any sells.

Hold patiently is the best policy imo

MM putting through a lot of misleading trades, some buys showing as sells, duplicate trades, wider spreads etc

ny boy
21/5/2019
14:32
They keep mugging a few each decade since 20p’s, some bought back and saw the opportunity, some are kicking themselves, even today a few big sells got mugged, basically why sell, unless you need the money!

Just buy & hold imo

This will really start motoring above 115p resistance.

ny boy
21/5/2019
14:25
That shake didn't last long now back up higher on day
78steve
21/5/2019
14:24
Solely from a momentum up to the FDA readout we have similarities to IMM but in the case here if we fail with FDA or get a very limited label which is In my opinion possible we are not going from 170 to 30p on the day.
We will have to spend more cash and time but with the new data already at hand we will get the extended label eventually I see continued rise up to say mid July then some sort of pullback ahead of results that is the usual pattern in these circumstances.
If we were to get FDA full label we may see a bidding battle which could lead to s takeout somewhere between £5/£7 depending on the interested parties and that could even be slightly conservative.

best1467
21/5/2019
14:19
There we go.....as predicted. How low will they take it?
nobbygnome
21/5/2019
13:22
To get back to STX, I am expecting a MM inspired tree shake in the not too distant future. If it happens, I will use the opportunity to get a few more....
nobbygnome
Chat Pages: Latest  135  134  133  132  131  130  129  128  127  126  125  124  Older

Your Recent History

Delayed Upgrade Clock